We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Concerns Raised Over Use of Electronic Cigarettes

By HospiMedica International staff writers
Posted on 17 Aug 2009
The U.S. More...
Food and Drug Administration (FDA, Silver Spring, MD, USA) and health experts have joined to warn consumers about potential health risks associated with electronic cigarettes.

The potential health risks were addressed in a telephone conference held during July 2009, headed by FDA principal deputy commissioner Joshua Sharfstein, M.D., and Matthew McKenna, M.D., the director of the Office of Smoking and Health for the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA). During the phone conference, which was shared with the news media, the FDA announced findings from a laboratory analysis by the division of pharmaceutical analysis--part of the FDA's Center for Drug Evaluation and Research--that analyzed the ingredients in a small sample of cartridges from two leading brands of e-cigarette samples. One sample was found to contain diethylene glycol, a toxic chemical used in antifreeze; several other samples were found to contain several carcinogens, including nitrosamines. The report also warned of concerns about the marketability of e-cigarettes to young people and their potential danger as a "gateway" product to actual smoking.

The conference participants stressed the importance of parents being aware of the health and marketing concerns associated with e-cigarettes. It was stated that parents might want to tell their children and teenagers that these products are not safe to use. Of particular concern to parents is that e-cigarettes are sold without any legal age restrictions, and are available in different flavors (such as chocolate, strawberry, and mint), which may appeal to the young. In addition, the devices do not contain any health warnings comparable to FDA-approved nicotine replacement products or conventional cigarettes.

The FDA has been examining and detaining shipments of e-cigarettes at the U.S. border and the products it has examined thus far meet the definition of a combination drug-device product under the U.S. Federal Food, Drug, and Cosmetic Act. The FDA has been challenged regarding its jurisdiction over certain e-cigarettes in a case currently pending in federal district court. The agency is also planning additional activities to address its concerns about these products.

"The FDA is concerned about the safety of these products and how they are marketed to the public,” said Margaret A. Hamburg, M.D., FDA commissioner of food and drugs.

Electronic cigarettes (also known as "e-cigarettes") are battery-operated devices designed to look like and to be used in the same manner as conventional cigarettes. The devices generally contain cartridges filled with nicotine, flavor, and other chemicals. They turn the nicotine, which is highly addictive, and other chemicals into a vapor that is inhaled by the user.


Related Links:
U.S. Food and Drug Administration
U.S. Centers for Disease Control and Prevention


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.